Vaccine Hoarding By Wealthy Nations Leaves Poorer Countries Behind
As wealthy countries pre-order enough doses to inoculate their populations multiple times over, poorer nations lose out on limited vaccine supply.
For people in the U.S., the U.K. and other wealthy nations, getting vaccinated against COVID-19 seems to be just around the corner.
But for billions around the globe, vaccination likely won't happen until 2022 — if not later.
"Rich nations are hoarding the supply by going into these advanced purchase agreements," said Gavin Yamey, director of Duke University's Center for Policy Impact in Global Health.
As a flurry of vaccine candidates moves through clinical trials and approval processes, the U.S. and other rich nations have already pre-ordered enough doses to inoculate their populations multiple times over.
They’re trying to hedge their bets in case some vaccines prove unsuccessful. But this leaves poorer countries with a much smaller slice of the vaccine supply.
Health experts say that's not just inequitable — it's also self-defeating.
"It really makes no sense for a rich country to only worry about itself. That rich country can never, ever hermetically seal itself off from the rest of the world," said Yamey.
In 67 developing or poor countries — most of them in Africa — only 10% of the population is set to get vaccinated next year, according to a new analysis by Amnesty International and other groups.
"It's very important to make sure that those populations across the world are vaccinated. And we're not focusing on vaccinating entire populations of only a few handful of countries," said Tamaryn Nelson, a health advisor at Amnesty International.
Unlike richer countries that are making bilateral deals with vaccine companies, these 67 nations rely entirely on a globally funded initiative to buy and distribute vaccines equitably.
But supply should increase over time.
"It is still likely to take perhaps into 2022 or 2023 before we can envisage global vaccine herd immunity," said Yamey.
Experts and advocates are calling on wealthy governments and pharmaceutical companies to do their part to ensure we reach that milestone as soon as possible.
"You could see the knowledge being shared, intellectual property being shared, additional doses being shared," said Yamey.
President Biden to end emergency declarations for COVID
Those free at home COVID tests are expected to be a thing of the past after the emergency declaration ends.By Tsvangirayi Mukwazhi / AP
President Biden to end COVID-19 emergencies May 11
This comes as lawmakers have already ended elements of the emergencies that kept millions of Americans insured during the pandemic.By Susan Walsh / AP
WHO says COVID remains an emergency but is in transition
The World Health Organization said there is still uncertainty in COVID-19's future, but the virus is at a "transition point."By Shutterstock
This young author is on a mission to make crayons more diverse
In 2020, Bellen Woodard rolled out More Than Peach crayons, which feature a variety of skin tones.By Scripps News
Beyoncé announces dates for 'Renaissance' world tour
Beyoncé's first tour in about four years will kick off in Stockholm, Sweden, on May 10.By Chris Pizzello / AP
Try the 'Frugal February Challenge' to help rebuild your savings
These simple tips can help you cut expenses and boost your bottom line this month.By Elise Amendola / AP